Congressional collaboration on DTC device ads
This article was originally published in The Gray Sheet
Executive Summary
Sen. Herb Kohl, D-Wis., wants to work with Rep. Bart Stupak, D-Mich., on addressing direct-to-consumer medical device advertisements, "to determine if moratoriums or other proposed restrictions" might be necessary for ads for restricted devices, the Senator writes in a Sept. 26 letter to Stupak, who is chairman of the House Energy and Commerce Committee's oversight sub-panel. Kohl notes that Stupak and Rep. John Dingell, D-Mich., chairman of the House Energy Committee, have asked drug firms to consider a two-year moratorium on DTC ads for new prescription drugs, as recommended by the Institute of Medicine. Kohl held a hearing Sept. 17 on DTC ads for devices ("1The Gray Sheet" Sept. 22, 2008, p. 3)
You may also be interested in...
Senate Explores Restrictions On Direct-To-Consumer Device Ads
Senate Special Committee on Aging Chairman Herb Kohl, D-Wis., is considering legislation to restrict direct-to-consumer advertising of medical devices
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.